Abstract
The potential influence of a circadian rhythm and its modulation by lithium on the stimulation of AP-1 DNA binding activity by the cholinergic agonist pilocarpine was investigated in rat cerebral cortex. Stimulation of AP-1 binding after pilocarpine (30 mg/kg) was evident within 1 h and was maximally stimulated by 200% at 2 h. Pilocarpine-stimulated AP-1 binding exhibited a circadian rhythm in AP-1 binding measured at 0800, 1200, and 1600 hours, 2 h after pilocarpine. Pilocarpine-stimulated AP-1 binding at 0800 hours was approximately twice the level measured at 1600 hours. After acute lithium treatment, pilocarpine administration induced generalized seizures after about 20 min and stimulated AP-1 binding which increased continuously for 4.5 h, at which time the stimulation was 900% above control. A circadian variation was apparent in AP-1 binding stimulated by acute lithium plus pilocarpine, with stimulation at 0800 hours being 1.5 times that at 1600 hours. After chronic lithium and pilocarpine, which also produced seizures, there was no circadianvariation in pilocarpine-stimulated AP-1 binding. Thus pilocarpine-induced AP-1 binding in rat cerebral cortex was influenced by a circadian rhythm, but this was abolished by chronic lithium administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barone P, Morelli M, Cicarelli G, Cozzolino A, DeJoanna G, Campanella G, DiChiara G (1993) Expression of c-Fos protein in the experimental epilepsy induced by pilocarpine. Synapse 14:1–9
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254
Casebolt TL, Jope RS (1991) Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol Psychiatry 29:233–243
Honchar MP, Olney JW, Sherman WR (1983) Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science 220:323–325
Hughes P, Dragunow M (1993) Muscarinic receptor-mediated induction of Fos protein in rat brain. Neurosci Lett 150:122–126
Hughes P, Dragunow M (1994) Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons. Mol Brain Res 24:166–178
Janowsky DS, El-Yousef MK, Davis JM, Sekerke HI (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2:632–635
Jope RS (1993) Lithium selectively potentiates cholinergic activity in rat brain. Prog Brain Res 98:317–322
Jope RS, Williams MB (1994) Lithium and brain signal transduction systems. Biol Pharmacol 47:429–441
Jope RS, Morrisett RA, Snead OC (1986) Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp Neurol 91:471–480
Kafka MS, Wirz-Justice A, Naber D, Marangos PJ, O'Donohue TL, Wehr TA (1982) Effect of lithium on circadian neurotransmitter receptor rhythms. Neuropsychobiology 8:41–50
Keefe DL, Earnest DJ, Nelson D, Takahashi JS, Turek FW (1987) A cholinergic antagonist, mecamylamine, blocks the phase-shifting effects of light on the circadian rhythm of locomotor activity in the golden hamster. Brain Res 403:308–312
Klemfuss H (1992) Rhythms and the pharmacology of lithium. Pharmacol Ther 56:53–78
Kripke DF, Mullaney DJ, Atkinson M, Wolf S (1978) Circadian rhythm disorders in manic-depressives. Biol Psychiatry 13:335–351
Manji HK, Lenox RH (1994) Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 16:11–28
Morgan JI, Curran T (1991) Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:421–451
Morrisett RA, Jope RS, Snead OC (1987) Status epilepticus is produced by administration of cholinergic agonists to lithiumtreated rats: comparison with kainic acid. Exp Neurol 98:594–605
Murphy BEP (1991) Steroids and depression. J Steroid Biochem Mol Biol 38:537–559
Ormandy GC, Jope RS, Snead OC (1989) Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Exp Neurol 106:172–180
Ormandy GC, Song L, Jope RS (1991) Analysis of the convulsant-potentiating effects of lithium in rats. Exp Neurol 111:356–361
Peiffer A, Veilleux S, Barden N (1991) Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology 16:505–515
Scheving LE, Pauly JE (1966) Effect of light on corticosterone levels in plasma of rats. Am J Physiol 210:1112–1117
Takeuchi J, Shannon W, Aronin N, Schwartz WJ (1993) Compositional changes of AP-1 DNA binding proteins are regulated by light in a mammalian circadian clock. Neuron 11:825–836
Unlap T, Jope RS (1994) Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. Mol Brain Res 24:275–282
Unlap T, Jope RS (1995) Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids. Mol Brain Res 28:193–200
Weiner ED, Kalasapudi VD, Papolos DF, Lachman HM, (1991) Lithium augments pilocarpine-induced fos gene expression in rat brain. Brain Res 553:117–122
Williams MB, Jope RS (1994) Distinctive rat brain immediate early gene responses to seizures induced by lithium plus pilocarpine. Mol Brain Res 25:80–89
Wood AJ, Goodwin GM (1987) A review of the biochemical and neuropharmacological actions of lithium. Psychol Med 17:79–600
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, M.B., Jope, R.S. Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology 122, 363–368 (1995). https://doi.org/10.1007/BF02246267
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246267